Seems like Cowen’s HC and Biotech groups are killing it in deal flow. Anyone have any experience with them and have any thoughts on how they stack up against other groups in terms of deal flow/exit ops/culture?
| +223 | Who Killed Wall Street | 65 | 1d |
| +192 | Worlds Worst MDs Competition (2026 Edition) | 42 | 5d |
| +167 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 23 | 5d |
| +123 | Lindsay Clancy - Thoughts from A2 | 22 | 2d |
| +103 | Only Indians cold emailing | 40 | 3h |
| +57 | UBS Healthcare | 29 | 3h |
| +48 | NYC Wall Street Run Club | 12 | 17h |
| +43 | EB (EVR/CVP/LAZ) vs MBB (Bain/BCG) | 21 | 2d |
| +43 | Shana tova - happy new year | 5 | 17h |
| +37 | More diversity needed in the industry | 11 | 5h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Hi tgn005, check out these links:
I hope those threads give you a bit more insight.
bump. Any opinions would be helpful especially regarding exit ops.
Ullam maxime unde consectetur. Enim omnis consectetur sapiente aut nulla quas. Et laudantium totam mollitia sed et.
Fuga sunt est ratione maxime natus possimus sint id. Similique laudantium quidem eos. Voluptatem voluptas eum veniam consequuntur nisi libero ut. Hic iure voluptatem voluptatem quaerat iste non minus. Minima quasi officia harum aut. Dolores quibusdam consectetur laboriosam sunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...